BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34983914)

  • 1. Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway.
    Wang K; Tang R; Wang S; Xiong Y; Wang W; Chen G; Zhang K; Li P; Tang YD
    J Cardiovasc Pharmacol; 2022 Feb; 79(2):217-228. PubMed ID: 34983914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.
    Wu Y; Leng Y; Meng Q; Xue R; Zhao B; Zhan L; Xia Z
    J Diabetes Res; 2017; 2017():8208065. PubMed ID: 28191472
    [No Abstract]   [Full Text] [Related]  

  • 3. HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury.
    Yang J; He J; Ismail M; Tweeten S; Zeng F; Gao L; Ballinger S; Young M; Prabhu SD; Rowe GC; Zhang J; Zhou L; Xie M
    J Mol Cell Cardiol; 2019 May; 130():36-48. PubMed ID: 30880250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
    Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
    Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
    Aune SE; Herr DJ; Mani SK; Menick DR
    J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.
    Herr DJ; Baarine M; Aune SE; Li X; Ball LE; Lemasters JJ; Beeson CC; Chou JC; Menick DR
    J Mol Cell Cardiol; 2018 Jan; 114():309-319. PubMed ID: 29224834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor SAHA exerts a protective effect against myocardial ischemia/reperfusion injury by inhibiting sodium-calcium exchanger.
    Shi X; Yin Y; Guo X; Liu M; Ma F; Tian L; Zheng M; Liu G
    Biochem Biophys Res Commun; 2023 Sep; 671():105-115. PubMed ID: 37300940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGC-1α Participates in the Protective Effect of Chronic Intermittent Hypobaric Hypoxia on Cardiomyocytes.
    Gu S; Hua H; Guo X; Jia Z; Zhang Y; Maslov LN; Zhang X; Ma H
    Cell Physiol Biochem; 2018; 50(5):1891-1902. PubMed ID: 30396162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.
    Zhang LX; Zhao Y; Cheng G; Guo TL; Chin YE; Liu PY; Zhao TC
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2154-63. PubMed ID: 20382965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
    Liu S; Ai Q; Feng K; Li Y; Liu X
    Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.
    Cavasin MA; Demos-Davies K; Horn TR; Walker LA; Lemon DD; Birdsey N; Weiser-Evans MC; Harral J; Irwin DC; Anwar A; Yeager ME; Li M; Watson PA; Nemenoff RA; Buttrick PM; Stenmark KR; McKinsey TA
    Circ Res; 2012 Mar; 110(5):739-48. PubMed ID: 22282194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation.
    Nural-Guvener HF; Zakharova L; Nimlos J; Popovic S; Mastroeni D; Gaballa MA
    Fibrogenesis Tissue Repair; 2014; 7():10. PubMed ID: 25024745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Xinmai'an tablets via mediation of the AMPK/SIRT1/PGC-1α signaling pathway on myocardial ischemia-reperfusion injury in rats.
    Zhang W; Chen R; Xu K; Guo H; Li C; Sun X
    Phytomedicine; 2023 Nov; 120():155034. PubMed ID: 37611465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
    Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
    J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
    Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
    Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1.
    Guo Z; Liao Z; Huang L; Liu D; Yin D; He M
    Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.
    Du J; Zhang L; Zhuang S; Qin GJ; Zhao TC
    J Cell Physiol; 2015 Jun; 230(6):1321-31. PubMed ID: 25475100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection by acetylcholine: a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway.
    Sun L; Zhao M; Yu XJ; Wang H; He X; Liu JK; Zang WJ
    J Cell Physiol; 2013 Jun; 228(6):1238-48. PubMed ID: 23139024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.
    Chen GH; Xu CS; Zhang J; Li Q; Cui HH; Li XD; Chang LP; Tang RJ; Xu JY; Tian XQ; Huang PS; Xu J; Jin C; Yang YJ
    Front Pharmacol; 2017; 8():775. PubMed ID: 29163161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.